S.Amdt. 911Senate119th Congress (2025-2027)
To establish a deficit-neutral reserve fund relating to increasing funding for research on Alzheimer's disease and related dementias.
Sponsored by
Sen. Edward J. Markey (D-MA)
Submitted February 20, 2025
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment not agreed to: Amendment SA 911 not agreed to in Senate by Voice Vote.
February 21, 2025
View full timeline
Floor
Senate amendment not agreed to: Amendment SA 911 not agreed to in Senate by Voice Vote.
February 21, 2025
Floor
Senate amendment proposed (on the floor): Amendment SA 911 proposed by Senator Markey.
February 21, 2025
Floor
Amendment SA 911 proposed by Senator Markey. (consideration: CR S1114) To establish a deficit-neutral reserve fund relating to increasing funding for research on Alzheimer's disease and related dementias.
February 21, 2025
Floor
Amendment SA 911 not agreed to in Senate by Voice Vote.
February 21, 2025
Floor
Senate amendment submitted
February 20, 2025
Text
Submitted
SA 911. Mr. MARKEY submitted an amendment intended to be proposed by him to the concurrent resolution S. Con. Res. 7, setting forth the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; which was ordered to lie on the table; as follows: At the end of title III, add the following: SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO INCREASING FUNDING FOR RESEARCH ON ALZHEIMER'S DISEASE AND RELATED DEMENTIAS. The Chairman of the Committee on the Budget of the Senate may revise the allocations of a committee or committees, aggregates, and other appropriate levels in this resolution, and make adjustments to the pay-as-you-go ledger, for one or more bills, joint resolutions, amendments, amendments between the Houses, motions, or conference reports relating to increasing funding for Alzheimer's disease and related dementias, which may include research conducted or funded by the National Institutes of Health, where such funding would contribute to improving the development of treatment and cures, reduce health care costs for families and taxpayers, improve support for caregivers, or safeguard the United States' global leadership in neurodegenerative disease research and innovation, by the amounts provided in such legislation for those purposes, provided that such legislation would not increase the deficit over the period of the total of fiscal years 2025 through 2034. ______